Sign In
29 Mar 2019 07:00
Ovoca Bio plc
("Ovoca" or the "Company")
Grant of Share Options
Ovoca Bio plc (LSE: OVB; ISE:OVXA), a biopharmaceutical company focused on identifying and developing novel therapeutics targeting the large unmet needs in the treatment of female sexual dysfunction, announces that options (the "Options") over ordinary shares with a nominal value of 12.5 cent each in the share capital of the Company ("Ordinary Shares") have been awarded to certain PDMRs of the Company pursuant to the 2009 Share Option Plan, as set out below. The Options have an exercise price of 12.5 cent, a vesting period of 3 years and are subject to the satisfaction of performance conditions. In aggregate, the Company has granted options over a total of 7,100,000 Ordinary Shares to the below PDMRs and other employees of the Company. There were no other Options outstanding in the share capital of the Company prior to the grant of the Options summarised above.
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Mikhail Mogutov
| ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Executive Chairman, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of €0.125. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Leonid Skoptsov | ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Non-Executive Director, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Yury Radchenko | ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Non-Executive Director, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Tim McCutcheon | ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Non-Executive Director, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Nikolay Myasoyedov | ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Non-Executive Director, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Chris Wiltshire | ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Non-Executive Director, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Romulo Colindres | ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Non-Executive Director, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name |
Kirill Golovanov | ||||
| ||||||
2 | Reason for the notification
| |||||
a) | Position/status |
Chief Executive Officer, PDMR
| ||||
b) | Initial Notification Amendment |
Initial Notification
| ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Ovoca Bio plc
| ||||
b) | LEI | 213800ST2AK5XQ1O5207
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of nominal value €0.125 each
ISIN: IE00B4XVDC01 | ||||
b) | Nature of the transaction |
Grant of share options under the 2009 Share Option Scheme
Options have an exercise price of 12.5c. Subject to three year vesting period from the date of grant, continued service and the satisfaction of certain performance conditions.
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
N/A (Single Transaction)
| ||||
e) | Date of the transaction |
27 March 2019
| ||||
f) | Place of the transaction |
Outside of a trading venue
| ||||
END
Contact Information:
Ovoca Bio plc
Kirill Golovanov (Chief Executive)
Tel +7 495 916 6029
info@ovocabio.com
Davy (Nominated Adviser, Euronext Growth Advisor and Broker)
John Frain / Daragh O'Reilly
Tel: +353 1 679 6363
Follow the stocks
